Inulin for heart health in people taking weight-loss injections
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests whether adding inulin, a type of fiber, to your diet can improve heart health and metabolism while you are taking a weight-loss injection like semaglutide or tirzepatide. If you qualify, you will take inulin for six months and have your health monitored.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 64 years old.
- You are overweight or obese (BMI 24 or higher, with a related condition like diabetes or high blood pressure, or BMI 28 or higher).
- You have been taking a weight-loss injection (like semaglutide, liraglutide, or tirzepatide) for at least 3 months and plan to keep taking it for the next 6 months.
- You are not currently using other weight-loss medications or planning weight-loss surgery in the next 4 months.
- You are not allergic to inulin-type fibers and have not regularly taken prebiotics or probiotics (like supplements) recently.
- You are not pregnant, planning to become pregnant in the next year, or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a plant-based supplement (called 20E) to the weight-loss medication semaglutide can improve weight loss and muscle health. You would take the supplement as capsules alongside your regular semaglutide treatment.
This study tests if taking inulin, a type of fiber, can help improve blood sugar control and immune health in people with type 1 diabetes. Participants will take a daily supplement for a period of time to see if it makes a difference.
This study tests whether taking a fiber supplement can improve gut health and blood vessel health in people with obesity. It may help you understand how your body responds to extra fiber.
This study tests a new injection (MWN117) in healthy people and in people with obesity. It aims to see if the drug is safe and how the body handles it, which may eventually help with weight management.
This study tests an experimental drug called IBI3042 in healthy people who are normal weight, overweight, or obese. It is an early-stage trial looking at how safe and tolerable the drug is, and how it affects the body, which could eventually lead to a treatment for weight loss.
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.